Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Clinical trial NCT07421700 · RECRUITING

Trial details

NCT number: NCT07421700
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Urothelial Cancer Advanced/Metastatic Urothelial Cancer Urothelial Carcinoma

Start date: 2026-03-11
Primary completion: 2027-12-06
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.